December 30, 2024
21 min listen
Save
The Role of Machine Learning in Clinical Trials with Damon Rasheed
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to better predict clinical trial outcomes, handling ethical concerns surrounding AI in health care and more.
- Welcome to another exciting episode of Oncology Overdrive 0:14
- About Rasheed 0:20
- The interview 0:58
- How did you end up in the AI-powered medicine and clinical trials? 1:48
- What is Opyl, and what is TrialKey? 3:54
- Is TrialKey predominantly based in Australia or is it available outside of Australia as well? 5:34
- Can you explain how machine learning works in order to create these outcomes?6:11
- How do you see people utilizing this tool in the future based on what you have already seen?8:30
- How have others received this? What is the feedback you have gotten surrounding what people are excited and concerned about with this technology?10:50
- Does this type of product take into account the issue of diversity in clinical trials?13:41
- What’s next for expanding Opyl and TrialKey?14:27
- What keeps you excited and motivated to continue working in this space?15:28
- If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 19:35
- How to contact Rasheed 20:16
- Thanks for listening 20:54
Damon Rasheed is a serial entrepreneur recognized for his groundbreaking ventures and deep expertise in machine learning and big data.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Rasheed can be reached at opyl.ai or trialkey.ai.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Jain reports no relevant financial disclosures. Rasheed reports TrialKey is powered by Opyl Limited, which is a publicly listed company operating on the ASX.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
